查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2012576

視網膜成像設備市場：2026-2032年全球市場預測（按設備類型、連接方式、便攜性、應用、最終用戶、適應症和分銷管道分類）

Retinal Imaging Devices Market by Device Type, Connectivity, Portability, Application, End User, Indication, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2024 年視網膜成像設備市場價值為 41.6 億美元，預計到 2025 年將成長至 44.7 億美元，複合年成長率為 8.01%，到 2032 年將達到 77 億美元。

主要市場統計數據
基準年 2024 41.6億美元
預計年份：2025年 44.7億美元
預測年份 2032 77億美元
複合年成長率 (%) 8.01%

本文重點概述了光學、感測器和軟體領域的最新技術創新如何改變了視網膜成像的臨床工作流程、診斷和部署過程。

視網膜成像設備已成為現代眼科不可或缺的工具，用於輔助診斷、後續觀察和研究視網膜疾病。光學設計、感測器技術和影像處理的進步，使得許多診斷功能得以從專業機構轉移到更廣泛的臨床環境。因此，臨床醫生能夠更早發現和治療疾病，改善患者預後，並推動社區篩檢和遠距眼科等新型醫療模式的發展。

對技術創新與醫療保健服務模式的融合進行了深入分析，這些融合正在加速視網膜成像領域的去中心化、互聯互通和臨床效用。

視網膜成像領域正經歷一場變革，主要得益於硬體技術的進步和軟體的智慧化發展。高解析度光學同調斷層掃描（OCT）和超廣角成像技術的各種改進，拓展了臨床醫生可用的非侵入性可視化手段，而自適應光學和掃描雷射視光技術則在檢查環境中實現了細胞和微血管級別的解析度。同時，影像分析技術的進步，包括用於病變檢測和進展監測的檢驗的機器學習模型，正在將原始影像轉化為可操作的臨床資訊。

對 2025 年貿易政策調整將如何重塑視網膜成像設備市場的供應鏈策略、採購經濟和服務路徑進行實際評估。

關稅措施和貿易政策調整的推出可能會對視網膜成像設備的供應鏈、定價策略和採購決策產生重大影響。 2025年實施的關稅調整迫使製造商、經銷商和醫療保健系統重新評估其籌資策略、區域製造地和庫存管理實務。由於這些設備通常包含來自全球各地的精密光學、感測器和電子元件，進口關稅的變化可能會對不同產品系列和型號造成不同的成本壓力。

將影像方式、最終用戶優先順序和臨床應用連結起來的多層次細分分析，明確了產品定位、實證策略和市場進入重點。

在視網膜成像領域，理解技術細分對於制定產品開發和打入市場策略至關重要。技術細分包括自適應光學成像、眼底成像、光學同調斷層掃描(OCT)、眼底鏡和超廣角成像。在眼底成像方面，彩色眼底照片和數位眼底照片在臨床和工作流程方面各有優劣。彩色影像便於臨床醫生直覺解讀，而數位方法則可與分析平台無縫整合。光學同調斷層掃描(OCT) 本身包括頻譜域 OCT、掃描源 OCT 和時域 OCT，每種技術都有不同的穿透深度、速度和解析度特性，以滿足特定的診斷需求。

區域比較觀點介紹影響美洲、歐洲、中東和非洲以及亞太市場採用的獨特贖回、監管和採用促進因素。

區域趨勢持續影響著美洲、歐洲、中東和非洲以及全部區域的市場優先事項和競爭策略。在美洲，受私人和公共保險公司報銷模式以及成熟的門診和醫院系統網路的共同推動，買家優先考慮能夠支持大規模篩檢和遠距眼科計畫的整合解決方案。因此，希望在美洲市場站穩腳跟的供應商必須展現出互通性、合規性和強大的商業性支援基礎。

詳細的競爭分析揭示了模式專家、成熟的醫學影像公司和軟體主導的新參與企業如何透過證據、服務模式和策略夥伴關係來競爭。

視網膜影像領域的競爭格局呈現出多元化的特點，既有成熟的醫療影像公司，也有專業的眼科醫療設備製造商，還有新興的軟體主導參與企業。老字型大小企業憑藉其廣泛的臨床產品組合、全球服務網路和豐富的監管合規經驗，確保與醫療機構建立長期的銷售合作關係。相較之下，專業製造商則傾向於透過專注於特定成像模式或特定臨床領域，投資於迭代式光學性能改進以及與臨床醫生夥伴關係，從而在競爭中脫穎而出。

為經營團隊提供切實可行的、優先考慮的建議，以協調產品、商業和供應鏈策略，從而加快產品部署並降低政策帶來的風險。

產業領導者應優先專注於三個切實可行的領域，以鞏固市場地位並提升臨床價值。首先，投資可互通的平台和檢驗的分析能力，確保設備能夠順利整合到不同的醫療環境中。這將降低醫院和門診中心採用設備的門檻，並加速臨床應用。其次，探索靈活的商業模式，例如租賃、計量收費和管理服務，以降低採購壁壘，並解決因貿易政策變化而加劇的總體擁有成本 (TCO) 問題。第三，制定區域打入市場策略，充分考慮當地的監管要求、報銷框架和臨床推廣網路，以最佳化資源配置並縮短實際部署時間。

對混合方法研究方法進行透明的解釋，該方法結合了主要臨床訪談、次要技術分析和檢驗，以檢驗研究結果及其意義。

本研究採用多層次調查方法，結合一手訪談、二手技術審查和嚴謹的檢驗，整合訊息，確保得出可靠的結論。一手研究包括與來自不同醫療機構的臨床負責人、生物醫學工程師、採購決策者和醫療設備技術人員進行結構化訪談，以了解實際應用中的促進因素和營運限制。此外，還透過對監管申報文件、臨床文獻、設備規格和公共衛生舉措的二手審查，補充了上述結論，從而更好地理解該技術的性能和部署模式。

簡明總結強調，技術、證據產生和實際商業性實施共同決定哪些創新將永續改變視網膜醫學。

視網膜成像領域正處於一個轉折點，光學技術創新、軟體驅動的智慧技術以及採購趨勢的轉變正在重新定義視網膜護理的提供方式。影像技術日趨強大且普及，推動了分散式診斷、可擴展篩檢和數據驅動型疾病管理的發展。同時，關於「醫療設備軟體（SaMD）」法規的明確以及近期貿易政策的調整，為供應商和買家都帶來了機會和挑戰。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章 視網膜影像設備市場：依設備類型分類

  • 眼底攝影機
    • 眼底攝影機
    • 眼底攝影機
  • 光學同調斷層掃描（OCT）系統
  • 廣域成像系統
  • 掃描雷射眼底鏡
  • 視網膜血管造影術系統

第9章 視網膜成像設備市場：連結性

  • 獨立系統
  • 網路連線系統
  • 雲端連線系統

第10章：視網膜成像設備市場－便攜性

  • 桌上型裝置
  • 直立式安裝設備
  • 手持裝置
  • 智慧型手機整合系統

第11章 視網膜影像設備市場：依應用領域分類

  • 疾病診斷與治療
  • 研究和推廣活動
  • 全身篩檢
  • 手術及術前計劃

第12章 視網膜成像設備市場：依最終用戶分類

  • 門診手術中心
  • 醫院和診所
  • 眼科診所
  • 社區健康檢查計劃
  • 學術和研究機構

第13章 視網膜影像設備市場：依適應症分類

  • 糖尿病視網膜病變
  • 視網膜靜脈阻塞
  • 青光眼
  • 老齡化黃斑部病變（AMD）
  • 葡萄膜炎和發炎性疾病

第14章 視網膜成像設備市場：依通路分類

  • 線上銷售
  • 線下銷售

第15章 視網膜影像設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第16章 視網膜影像設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第17章 視網膜成像設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第18章：美國視網膜影像設備市場

第19章：中國視網膜成像設備市場

第20章 競爭格局

  • 2024年市場集中度分析
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2024 年
  • 2024年產品系列分析
  • 基準分析，2024 年
  • Alcon Inc.
  • Bausch Health Companies Inc.
  • Canon Inc.
  • Carl Zeiss AG
  • EssilorLuxottica SA
  • Kowa Company, Ltd.
  • NIDEK Co., Ltd.
  • Nikon Corporation
  • Optomed Plc
  • Topcon Corporation
Product Code: MRR-433C4187C5C4

The Retinal Imaging Devices Market was valued at USD 4.16 billion in 2024 and is projected to grow to USD 4.47 billion in 2025, with a CAGR of 8.01%, reaching USD 7.70 billion by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 4.16 billion
Estimated Year [2025] USD 4.47 billion
Forecast Year [2032] USD 7.70 billion
CAGR (%) 8.01%

A focused overview of how recent optical, sensor, and software breakthroughs have reshaped clinical workflows, diagnostics, and adoption pathways in retinal imaging

Retinal imaging devices have become indispensable in modern ophthalmic care, powering diagnosis, monitoring, and research into retinal disease. Advances in optical design, sensor technology, and image processing have shifted many diagnostic capabilities from specialized centers into broader clinical settings. As a consequence, clinicians are increasingly able to detect and manage conditions earlier, improving patient outcomes and enabling new models of care such as community screening and teleophthalmology.

Over the past several years, innovations in imaging modalities have converged with software-driven analytics to expand clinical utility. Higher-resolution imaging, faster acquisition times, and non-invasive modalities have reduced patient burden while enhancing diagnostic confidence. Regulatory approvals for novel imaging systems and incremental software enhancements have lowered barriers to clinical integration, prompting healthcare providers to reassess technology portfolios and workflow configurations.

Transitioning from research-only environments to routine clinical deployment requires attention to interoperability, training, reimbursement pathways, and workflow redesign. Consequently, stakeholders must weigh device performance against operational realities, including technician skill mix, integration with electronic health records, and downstream referral protocols. This introduction frames the subsequent analysis by laying out the technical, clinical, and operational drivers that shape adoption and the competitive environment for retinal imaging devices.

An incisive analysis of converging technical innovations and care delivery models that are accelerating decentralization, connectivity, and clinical utility in retinal imaging

The retinal imaging landscape is undergoing transformative shifts driven by both hardware refinement and software intelligence. High-resolution optical coherence tomography variants and ultrawide field imaging are extending the boundaries of what clinicians can visualize non-invasively, while adaptive optics and scanning laser ophthalmoscopy are enabling cellular and microvascular resolution in research settings. Simultaneously, advances in image analysis, including machine learning models validated for lesion detection and progression monitoring, are converting raw images into actionable clinical insights.

These technical advances are altering where and how care is delivered. Diagnostic capabilities that were once confined to tertiary centers are moving into ambulatory surgical centers and community clinics through devices optimized for speed, ergonomics, and ease of use. Furthermore, the integration of imaging with telemedicine platforms and cloud-based workflows is enabling remote screening programs and specialist review, reshaping referral patterns and capacity planning. Payment and reimbursement mechanisms are gradually adapting to these new modalities, which in turn affects procurement timing and prioritization.

In parallel, regulatory authorities are evolving their frameworks for software as a medical device, bringing clarity to validation expectations for algorithmic tools used alongside imaging hardware. Consequently, manufacturers are investing in clinical evidence generation and post-market surveillance to support claims and facilitate wider clinical adoption. Taken together, these shifts are accelerating hybrid models of care where devices, analytics, and connectivity coalesce to improve access and diagnostic precision.

A pragmatic evaluation of how 2025 trade policy adjustments are reshaping supply chain strategy, procurement economics, and service-based pathways across retinal imaging device markets

The introduction of tariff measures and trade policy adjustments can materially influence supply chains, pricing strategies, and procurement decisions for retinal imaging devices. Tariff adjustments enacted in 2025 have prompted manufacturers, distributors, and health systems to reassess sourcing strategies, regional manufacturing footprints, and inventory management practices. As devices comprise precision optical components, sensors, and electronics often sourced globally, changes in import duties can create differential cost pressures across product families and variants.

In response, several suppliers have pursued geographic diversification of manufacturing and assembly operations, evaluating options that mitigate exposure to single-country tariff regimes. These supply chain adjustments are accompanied by contract renegotiations with component suppliers and a reevaluation of total landed cost models. Purchasing organizations are similarly revisiting tender specifications and total cost of ownership calculations, weighing higher unit costs against reliability, warranty terms, and clinical support arrangements.

Importantly, tariff-driven cost impacts have also accelerated interest in modularity and service-based models. Where capital expenditure becomes more complex, service contracts, leasing arrangements, and software-centric licensing offer alternative pathways for healthcare providers to access advanced imaging capabilities without immediate large capital outlay. Over time, sustained policy volatility may spur deeper localization of critical component manufacturing, strategic inventory buffers, and collaborative sourcing consortia to optimize resilience across the retinal imaging value chain.

A layered segmentation analysis linking imaging modalities, end-user priorities, and clinical applications to refine product positioning, evidence strategy, and go-to-market focus

Understanding segmentation is essential to align product development and market engagement strategies in retinal imaging. The technology segmentation covers adaptive optics imaging, fundus imaging, optical coherence tomography, scanning laser ophthalmoscope, and ultrawide field imaging. Within fundus imaging, color fundus photography and digital fundus photography represent distinct clinical and workflow trade-offs, with color imaging providing intuitive clinicians' interpretation and digital variants enabling smoother integration with analytics platforms. Optical coherence tomography itself spans spectral domain OCT, swept source OCT, and time domain OCT, each offering different penetration, speed, and resolution characteristics that map to particular diagnostic needs.

End-user segmentation distinguishes ambulatory surgical centers, hospitals and clinics, and research institutions, each with unique procurement criteria. Ambulatory surgical centers typically prioritize throughput, footprint efficiency, and rapid training curves, while hospitals and clinics emphasize interoperability with hospital information systems, multi-modality capability, and lifecycle service support. Research institutions focus on the highest technical specifications and extensibility for experimental protocols, often accepting higher complexity for advanced imaging capabilities.

Application segmentation-diagnostic, research, and screening-further refines product positioning. Diagnostic applications demand validated performance, robust quality controls, and clinician-friendly outputs. Research applications prize customization, raw data access, and modularity. Screening programs emphasize cost-effectiveness, automation, and seamless referral pathways. Crosswalking these segmentation layers enables targeted value propositions, aligning device features, service models, and evidence generation strategies to the needs of each adopter type.

A comparative regional perspective highlighting distinct reimbursement, regulatory, and deployment drivers shaping adoption across the Americas, Europe Middle East & Africa, and Asia-Pacific markets

Regional dynamics continue to shape market priorities and competitive approaches across the Americas, Europe, Middle East & Africa, and Asia-Pacific. In the Americas, purchasers emphasize integrated solutions that support large-scale screening and teleophthalmology initiatives, driven by a mix of private and public payer reimbursement models and an established network of ambulatory and hospital systems. Consequently, vendors seeking traction in the Americas must demonstrate interoperability, regulatory compliance, and strong commercial support infrastructure.

Across Europe, Middle East & Africa, regulatory harmonization in some jurisdictions and variable reimbursement landscapes in others create a heterogeneous environment. Manufacturers need to tailor market entry strategies to local approval pathways and clinical champion networks. The emphasis on value-based care in parts of Europe also elevates the importance of outcomes evidence and cost-effectiveness demonstrations.

The Asia-Pacific region is characterized by rapid adoption in urban centers, a wide variance in healthcare infrastructure, and strong demand for scalable screening solutions to address population-level retinal disease burden. Local manufacturing and partnerships with regional distributors often accelerate market access, while digital health initiatives and public-private screening programs create opportunities for innovative deployment models. In each region, alignment with local clinical needs, regulatory contexts, and procurement norms remains critical to successful adoption.

A nuanced competitive review revealing how modality specialists, established imaging firms, and software-first entrants are competing through evidence, service models, and strategic partnerships

Competitive dynamics in the retinal imaging space are characterized by a mix of established medical imaging firms, specialist ophthalmic device manufacturers, and emergent software-driven entrants. Established firms leverage broad clinical portfolios, global service networks, and deep regulatory experience to secure institutional sales and long-term service contracts. Specialist manufacturers, in contrast, often focus on modality leadership or specific clinical niches, investing in iterative optical improvements and clinician partnerships to differentiate on performance.

Meanwhile, software-first entrants-particularly those focused on image analysis, lesion detection, and workflow automation-are reshaping expectations around device intelligence and downstream value. Partnerships and alliances between hardware vendors and analytics companies have become commonplace as manufacturers seek to embed validated algorithms into their devices or platform offerings. Additionally, contract service providers and third-party integrators play an influential role by enabling scalable deployments across networks of clinics and screening programs.

Across these segments, successful players demonstrate disciplined clinical evidence generation, responsive field service, and flexible commercial models that account for diverse procurement constraints. Strategic activities such as targeted clinical studies, interoperability certifications, and regional distribution partnerships continue to be primary levers by which companies expand adoption and reinforce competitive moats.

Practical and priority-driven recommendations for executives to align product, commercial, and supply chain strategies to accelerate adoption and mitigate policy-driven risks

Industry leaders should prioritize three actionable areas to strengthen market position and deliver clinical value. First, invest in interoperable platforms and validated analytics to ensure devices integrate smoothly into diverse care settings; this reduces friction for hospitals and ambulatory centers and accelerates clinical adoption. Second, explore flexible commercial models such as leasing, pay-per-use, and managed service offerings to lower procurement barriers and address total cost of ownership concerns intensified by trade policy variability. Third, develop region-specific market entry playbooks that account for local regulatory expectations, reimbursement frameworks, and clinical champion networks to optimize resource allocation and shorten time to meaningful adoption.

In parallel, manufacturers should reinforce post-market surveillance and real-world evidence collection to substantiate claims and support regulatory compliance for software-enabled features. Collaborations with research institutions can accelerate validation while also fostering clinician advocacy. Lastly, supply chain resilience must be prioritized through multi-sourcing of critical optics and electronics, strategic inventory buffers, and selective localization strategies to manage exposure to tariff shifts and logistics disruption. Taken together, these actions create a pragmatic roadmap for companies to enhance competitiveness and clinical impact.

A transparent description of a mixed-methods research approach combining primary clinical interviews, secondary technical analysis, and triangulation to validate findings and implications

This research synthesizes information from a layered methodology combining primary interviews, secondary technical review, and rigorous triangulation to ensure robust findings. Primary research included structured discussions with clinical leaders, biomedical engineers, procurement decision-makers, and device technicians across multiple care settings to capture real-world adoption drivers and operational constraints. These insights were complemented by secondary review of regulatory filings, clinical literature, device specifications, and public health initiatives to contextualize technology performance and deployment models.

Data triangulation was applied to reconcile differing perspectives and validate thematic conclusions. Clinical endpoints and workflow impacts were assessed through analysis of peer-reviewed studies and device technical documentation, while supply chain and procurement insights were informed by interviews with manufacturers, distributors, and hospital supply managers. Quality assurance measures included cross-validation of technical claims against independent clinical evaluations and consistency checks with public regulatory records.

This mixed-methods approach ensures that the analysis balances technical accuracy with commercial relevance, producing findings that are both evidence-based and actionable for stakeholders involved in product development, clinical adoption, and strategic planning.

A concise synthesis emphasizing that technology, evidence generation, and pragmatic commercial execution together determine which innovations will sustainably transform retinal care

The retinal imaging arena is at an inflection point where optical innovations, software intelligence, and altered procurement dynamics converge to redefine how retinal care is delivered. Imaging modalities are becoming more capable and accessible, enabling shifts toward decentralized diagnostics, scalable screening, and data-driven disease management. At the same time, evolving regulatory clarity for software-as-a-medical-device and recent trade policy adjustments introduce both opportunities and complexities for suppliers and purchasers.

To navigate this landscape, stakeholders must adopt a dual focus on technological relevance and operational integration. Manufacturers need to design systems that deliver clinical value while minimizing workflow disruption, and healthcare organizations must adapt procurement and training processes to fully capture diagnostic gains. Strategic partnerships, targeted clinical evidence programs, and resilient supply chain configurations will be decisive factors in determining which products and providers gain sustained adoption.

Ultimately, the most successful strategies will combine rigorous clinical validation, flexible commercial models, and regionally informed go-to-market execution, thereby ensuring that advances in retinal imaging translate into measurable improvements in patient care and system efficiency.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2024
  • 3.5. FPNV Positioning Matrix, 2024
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Retinal Imaging Devices Market, by Device Type

  • 8.1. Fundus Cameras
    • 8.1.1. Mydriatic Fundus Cameras
    • 8.1.2. Non-Mydriatic Fundus Cameras
  • 8.2. Optical Coherence Tomography Systems
  • 8.3. Wide-Field Imaging Systems
  • 8.4. Scanning Laser Ophthalmoscopes
  • 8.5. Retinal Angiography Systems

9. Retinal Imaging Devices Market, by Connectivity

  • 9.1. Standalone Systems
  • 9.2. Networked Systems
  • 9.3. Cloud-Connected Systems

10. Retinal Imaging Devices Market, by Portability

  • 10.1. Tabletop Devices
  • 10.2. Stand-Mounted Devices
  • 10.3. Handheld Devices
  • 10.4. Smartphone-Enabled Systems

11. Retinal Imaging Devices Market, by Application

  • 11.1. Disease Diagnosis & Management
  • 11.2. Research & Outreach
  • 11.3. Systemic Screening
  • 11.4. Surgical & Pre-operative Planning

12. Retinal Imaging Devices Market, by End User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals & Clinics
  • 12.3. Ophthalmology Clinics
  • 12.4. Community Screening Programs
  • 12.5. Academic & Research Institutes

13. Retinal Imaging Devices Market, by Indication

  • 13.1. Diabetic Retinopathy
  • 13.2. Retinal Vein Occlusion
  • 13.3. Glaucoma
  • 13.4. Age-Related Macular Degeneration (AMD)
  • 13.5. Uveitis & Inflammatory Diseases

14. Retinal Imaging Devices Market, by Distribution Channel

  • 14.1. Online Sales
  • 14.2. Offline Sales

15. Retinal Imaging Devices Market, by Region

  • 15.1. Americas
    • 15.1.1. North America
    • 15.1.2. Latin America
  • 15.2. Europe, Middle East & Africa
    • 15.2.1. Europe
    • 15.2.2. Middle East
    • 15.2.3. Africa
  • 15.3. Asia-Pacific

16. Retinal Imaging Devices Market, by Group

  • 16.1. ASEAN
  • 16.2. GCC
  • 16.3. European Union
  • 16.4. BRICS
  • 16.5. G7
  • 16.6. NATO

17. Retinal Imaging Devices Market, by Country

  • 17.1. United States
  • 17.2. Canada
  • 17.3. Mexico
  • 17.4. Brazil
  • 17.5. United Kingdom
  • 17.6. Germany
  • 17.7. France
  • 17.8. Russia
  • 17.9. Italy
  • 17.10. Spain
  • 17.11. China
  • 17.12. India
  • 17.13. Japan
  • 17.14. Australia
  • 17.15. South Korea

18. United States Retinal Imaging Devices Market

19. China Retinal Imaging Devices Market

20. Competitive Landscape

  • 20.1. Market Concentration Analysis, 2024
    • 20.1.1. Concentration Ratio (CR)
    • 20.1.2. Herfindahl Hirschman Index (HHI)
  • 20.2. Recent Developments & Impact Analysis, 2024
  • 20.3. Product Portfolio Analysis, 2024
  • 20.4. Benchmarking Analysis, 2024
  • 20.5. Alcon Inc.
  • 20.6. Bausch Health Companies Inc.
  • 20.7. Canon Inc.
  • 20.8. Carl Zeiss AG
  • 20.9. EssilorLuxottica SA
  • 20.10. Kowa Company, Ltd.
  • 20.11. NIDEK Co., Ltd.
  • 20.12. Nikon Corporation
  • 20.13. Optomed Plc
  • 20.14. Topcon Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL RETINAL IMAGING DEVICES MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 3. GLOBAL RETINAL IMAGING DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
  • FIGURE 4. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY CONNECTIVITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY INDICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. UNITED STATES RETINAL IMAGING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 15. CHINA RETINAL IMAGING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY FUNDUS CAMERAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY FUNDUS CAMERAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY FUNDUS CAMERAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY FUNDUS CAMERAS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY MYDRIATIC FUNDUS CAMERAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY MYDRIATIC FUNDUS CAMERAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY MYDRIATIC FUNDUS CAMERAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY NON-MYDRIATIC FUNDUS CAMERAS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY NON-MYDRIATIC FUNDUS CAMERAS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY NON-MYDRIATIC FUNDUS CAMERAS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY OPTICAL COHERENCE TOMOGRAPHY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY WIDE-FIELD IMAGING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY WIDE-FIELD IMAGING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY WIDE-FIELD IMAGING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY SCANNING LASER OPHTHALMOSCOPES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY SCANNING LASER OPHTHALMOSCOPES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY SCANNING LASER OPHTHALMOSCOPES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY RETINAL ANGIOGRAPHY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY RETINAL ANGIOGRAPHY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY RETINAL ANGIOGRAPHY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY STANDALONE SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY STANDALONE SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY STANDALONE SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY NETWORKED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY NETWORKED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY NETWORKED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY CLOUD-CONNECTED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY CLOUD-CONNECTED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY CLOUD-CONNECTED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY TABLETOP DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY TABLETOP DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY TABLETOP DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY STAND-MOUNTED DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY STAND-MOUNTED DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY STAND-MOUNTED DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY HANDHELD DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY HANDHELD DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY HANDHELD DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY SMARTPHONE-ENABLED SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY SMARTPHONE-ENABLED SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY SMARTPHONE-ENABLED SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY DISEASE DIAGNOSIS & MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY DISEASE DIAGNOSIS & MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY DISEASE DIAGNOSIS & MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY RESEARCH & OUTREACH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY RESEARCH & OUTREACH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY RESEARCH & OUTREACH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY SYSTEMIC SCREENING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY SYSTEMIC SCREENING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY SYSTEMIC SCREENING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY SURGICAL & PRE-OPERATIVE PLANNING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY SURGICAL & PRE-OPERATIVE PLANNING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY SURGICAL & PRE-OPERATIVE PLANNING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY OPHTHALMOLOGY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY COMMUNITY SCREENING PROGRAMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY COMMUNITY SCREENING PROGRAMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY COMMUNITY SCREENING PROGRAMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY RETINAL VEIN OCCLUSION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY RETINAL VEIN OCCLUSION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY RETINAL VEIN OCCLUSION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY GLAUCOMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY GLAUCOMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY GLAUCOMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION (AMD), BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION (AMD), BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY AGE-RELATED MACULAR DEGENERATION (AMD), BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY UVEITIS & INFLAMMATORY DISEASES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY UVEITIS & INFLAMMATORY DISEASES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY UVEITIS & INFLAMMATORY DISEASES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY ONLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY ONLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY OFFLINE SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY OFFLINE SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY OFFLINE SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS RETINAL IMAGING DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS RETINAL IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS RETINAL IMAGING DEVICES MARKET SIZE, BY FUNDUS CAMERAS, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS RETINAL IMAGING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS RETINAL IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS RETINAL IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS RETINAL IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS RETINAL IMAGING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS RETINAL IMAGING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA RETINAL IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA RETINAL IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA RETINAL IMAGING DEVICES MARKET SIZE, BY FUNDUS CAMERAS, 2018-2032 (USD MILLION)
  • TABLE 113. NORTH AMERICA RETINAL IMAGING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 114. NORTH AMERICA RETINAL IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 115. NORTH AMERICA RETINAL IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 116. NORTH AMERICA RETINAL IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA RETINAL IMAGING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA RETINAL IMAGING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA RETINAL IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA RETINAL IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA RETINAL IMAGING DEVICES MARKET SIZE, BY FUNDUS CAMERAS, 2018-2032 (USD MILLION)
  • TABLE 122. LATIN AMERICA RETINAL IMAGING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 123. LATIN AMERICA RETINAL IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 124. LATIN AMERICA RETINAL IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. LATIN AMERICA RETINAL IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. LATIN AMERICA RETINAL IMAGING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 127. LATIN AMERICA RETINAL IMAGING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA RETINAL IMAGING DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA RETINAL IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA RETINAL IMAGING DEVICES MARKET SIZE, BY FUNDUS CAMERAS, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA RETINAL IMAGING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA RETINAL IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA RETINAL IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA RETINAL IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA RETINAL IMAGING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA RETINAL IMAGING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE RETINAL IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE RETINAL IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE RETINAL IMAGING DEVICES MARKET SIZE, BY FUNDUS CAMERAS, 2018-2032 (USD MILLION)
  • TABLE 140. EUROPE RETINAL IMAGING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 141. EUROPE RETINAL IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 142. EUROPE RETINAL IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. EUROPE RETINAL IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. EUROPE RETINAL IMAGING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE RETINAL IMAGING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST RETINAL IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST RETINAL IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST RETINAL IMAGING DEVICES MARKET SIZE, BY FUNDUS CAMERAS, 2018-2032 (USD MILLION)
  • TABLE 149. MIDDLE EAST RETINAL IMAGING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 150. MIDDLE EAST RETINAL IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 151. MIDDLE EAST RETINAL IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 152. MIDDLE EAST RETINAL IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. MIDDLE EAST RETINAL IMAGING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 154. MIDDLE EAST RETINAL IMAGING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA RETINAL IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA RETINAL IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA RETINAL IMAGING DEVICES MARKET SIZE, BY FUNDUS CAMERAS, 2018-2032 (USD MILLION)
  • TABLE 158. AFRICA RETINAL IMAGING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 159. AFRICA RETINAL IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 160. AFRICA RETINAL IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 161. AFRICA RETINAL IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 162. AFRICA RETINAL IMAGING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 163. AFRICA RETINAL IMAGING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC RETINAL IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC RETINAL IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC RETINAL IMAGING DEVICES MARKET SIZE, BY FUNDUS CAMERAS, 2018-2032 (USD MILLION)
  • TABLE 167. ASIA-PACIFIC RETINAL IMAGING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 168. ASIA-PACIFIC RETINAL IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 169. ASIA-PACIFIC RETINAL IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 170. ASIA-PACIFIC RETINAL IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 171. ASIA-PACIFIC RETINAL IMAGING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 172. ASIA-PACIFIC RETINAL IMAGING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN RETINAL IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN RETINAL IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN RETINAL IMAGING DEVICES MARKET SIZE, BY FUNDUS CAMERAS, 2018-2032 (USD MILLION)
  • TABLE 177. ASEAN RETINAL IMAGING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 178. ASEAN RETINAL IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 179. ASEAN RETINAL IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 180. ASEAN RETINAL IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. ASEAN RETINAL IMAGING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 182. ASEAN RETINAL IMAGING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 183. GCC RETINAL IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. GCC RETINAL IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 185. GCC RETINAL IMAGING DEVICES MARKET SIZE, BY FUNDUS CAMERAS, 2018-2032 (USD MILLION)
  • TABLE 186. GCC RETINAL IMAGING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 187. GCC RETINAL IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 188. GCC RETINAL IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 189. GCC RETINAL IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 190. GCC RETINAL IMAGING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 191. GCC RETINAL IMAGING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION RETINAL IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION RETINAL IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION RETINAL IMAGING DEVICES MARKET SIZE, BY FUNDUS CAMERAS, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPEAN UNION RETINAL IMAGING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPEAN UNION RETINAL IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPEAN UNION RETINAL IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPEAN UNION RETINAL IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPEAN UNION RETINAL IMAGING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 200. EUROPEAN UNION RETINAL IMAGING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS RETINAL IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS RETINAL IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS RETINAL IMAGING DEVICES MARKET SIZE, BY FUNDUS CAMERAS, 2018-2032 (USD MILLION)
  • TABLE 204. BRICS RETINAL IMAGING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 205. BRICS RETINAL IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 206. BRICS RETINAL IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 207. BRICS RETINAL IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. BRICS RETINAL IMAGING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 209. BRICS RETINAL IMAGING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 210. G7 RETINAL IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. G7 RETINAL IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 212. G7 RETINAL IMAGING DEVICES MARKET SIZE, BY FUNDUS CAMERAS, 2018-2032 (USD MILLION)
  • TABLE 213. G7 RETINAL IMAGING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 214. G7 RETINAL IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 215. G7 RETINAL IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 216. G7 RETINAL IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 217. G7 RETINAL IMAGING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 218. G7 RETINAL IMAGING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 219. NATO RETINAL IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. NATO RETINAL IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. NATO RETINAL IMAGING DEVICES MARKET SIZE, BY FUNDUS CAMERAS, 2018-2032 (USD MILLION)
  • TABLE 222. NATO RETINAL IMAGING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 223. NATO RETINAL IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 224. NATO RETINAL IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 225. NATO RETINAL IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 226. NATO RETINAL IMAGING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 227. NATO RETINAL IMAGING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 228. GLOBAL RETINAL IMAGING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES RETINAL IMAGING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES RETINAL IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES RETINAL IMAGING DEVICES MARKET SIZE, BY FUNDUS CAMERAS, 2018-2032 (USD MILLION)
  • TABLE 232. UNITED STATES RETINAL IMAGING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 233. UNITED STATES RETINAL IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 234. UNITED STATES RETINAL IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 235. UNITED STATES RETINAL IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 236. UNITED STATES RETINAL IMAGING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 237. UNITED STATES RETINAL IMAGING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 238. CHINA RETINAL IMAGING DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 239. CHINA RETINAL IMAGING DEVICES MARKET SIZE, BY DEVICE TYPE, 2018-2032 (USD MILLION)
  • TABLE 240. CHINA RETINAL IMAGING DEVICES MARKET SIZE, BY FUNDUS CAMERAS, 2018-2032 (USD MILLION)
  • TABLE 241. CHINA RETINAL IMAGING DEVICES MARKET SIZE, BY CONNECTIVITY, 2018-2032 (USD MILLION)
  • TABLE 242. CHINA RETINAL IMAGING DEVICES MARKET SIZE, BY PORTABILITY, 2018-2032 (USD MILLION)
  • TABLE 243. CHINA RETINAL IMAGING DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. CHINA RETINAL IMAGING DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. CHINA RETINAL IMAGING DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 246. CHINA RETINAL IMAGING DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)